Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study.
Ding Y, Li W, Guan X, Liu N, Zhou Y, Li G, Wang X, Wang Z, Xiao X, Yang B, Lv C, Zhang C, Shi Y.
Ding Y, et al.
Clin Transl Sci. 2023 Oct;16(10):1803-1814. doi: 10.1111/cts.13583. Epub 2023 Aug 29.
Clin Transl Sci. 2023.
PMID: 37644777
Free PMC article.
Dermatologists documented the treatment dosage and modification reasons. Of the 244 secukinumab-naive patients, most were men (73.4%, 179/244) and weighed 60-90 kg (72.8%, 177/243). The mean (SD) age at secukinumab initiation was 38.1 (11.6) years, and the disease duration …
Dermatologists documented the treatment dosage and modification reasons. Of the 244 secukinumab-naive patients, most were men (73.4%, …